These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2458796

  • 1. The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.
    Cooper SJ, Leahey W, Green DF, King DJ.
    Br J Psychiatry; 1988 Jan; 152():59-63. PubMed ID: 2458796
    [Abstract] [Full Text] [Related]

  • 2. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
    Härnryd C, Bjerkenstedt L, Grimm VE, Sedvall G.
    Psychopharmacology (Berl); 1979 Aug 08; 64(2):131-4. PubMed ID: 115032
    [Abstract] [Full Text] [Related]

  • 3. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A, Ninan P, Mazonson A, Pickar D, Van Kammen D, Linnoila M, Paul SM.
    Psychol Med; 1985 May 08; 15(2):335-40. PubMed ID: 2410941
    [Abstract] [Full Text] [Related]

  • 4. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC, Wode-Helgodt B.
    Arch Gen Psychiatry; 1980 Oct 08; 37(10):1113-6. PubMed ID: 6158928
    [Abstract] [Full Text] [Related]

  • 5. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R, Roos BE, Kampman R, Hyyppä S, Ranta P, Myllylä V.
    Ann Clin Res; 1979 Feb 08; 11(1):25-9. PubMed ID: 453776
    [Abstract] [Full Text] [Related]

  • 6. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov 08; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 7. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D.
    Arch Gen Psychiatry; 1993 Aug 08; 50(8):606-14. PubMed ID: 7688209
    [Abstract] [Full Text] [Related]

  • 8. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug 08; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 9. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.
    J Clin Psychopharmacol; 2010 Oct 08; 30(5):496-503. PubMed ID: 20814316
    [Abstract] [Full Text] [Related]

  • 10. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest.
    Odink J, Kärkelä J, Thissen JT, Marnela KM.
    Acta Neurol Scand; 1989 Jul 08; 80(1):6-11. PubMed ID: 2476907
    [Abstract] [Full Text] [Related]

  • 11. The effect of propranolol on CSF amine metabolites in psychiatric patients.
    King DJ, Cooper SJ, Liddle J.
    Br J Clin Pharmacol; 1983 Mar 08; 15(3):331-7. PubMed ID: 6189502
    [Abstract] [Full Text] [Related]

  • 12. Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
    Degrell I, Nagy E.
    Biol Psychiatry; 1990 May 15; 27(10):1179-82. PubMed ID: 1692743
    [No Abstract] [Full Text] [Related]

  • 13. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M, Ninan PT, Scheinin M, Waters RN, Chang WH, Bartko J, van Kammen DP.
    Arch Gen Psychiatry; 1983 Dec 15; 40(12):1290-4. PubMed ID: 6197036
    [Abstract] [Full Text] [Related]

  • 14. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
    Tang HZ, Lu XF, Wang KJ, Ouyang S, Huang YQ.
    Mol Chem Neuropathol; 1989 Apr 15; 10(2):77-85. PubMed ID: 2472800
    [Abstract] [Full Text] [Related]

  • 15. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G.
    Prog Biochem Pharmacol; 1980 Apr 15; 16():133-40. PubMed ID: 6160594
    [Abstract] [Full Text] [Related]

  • 16. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM, Tsementzis SA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1979 Oct 15; 42(10):887-91. PubMed ID: 512664
    [Abstract] [Full Text] [Related]

  • 17. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 15; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 18. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
    Freed DM, Corkin S, Growdon JH, Nissen MJ.
    Neuropsychologia; 1988 Jul 15; 26(6):895-902. PubMed ID: 2461537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P, Verrier M, Warsh JJ, Price KS.
    J Neurol Neurosurg Psychiatry; 1976 Dec 15; 39(12):1191-200. PubMed ID: 1011029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.